# Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes

Study · id `cardio:ct-nct07521475` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07521475](<https://clinicaltrials.gov/study/NCT07521475>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07521475

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 350 participants.

## Technical summary

Registry record NCT07521475. Randomized; no masking; primary purpose treatment. Start 2026-04-30 (actual); primary completion 2026-12-24 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 350 participants (planned count; ClinicalTrials.gov record NCT07521475, source copy `cardio:ctgov-nct07521475-2026-08-03`, retrieved 2026-10-26)
- Started: 2026-04-30 (actual) (ClinicalTrials.gov record NCT07521475, source copy `cardio:ctgov-nct07521475-2026-08-03`, retrieved 2026-10-26)
- Primary completion: 2026-12-24 (anticipated) (ClinicalTrials.gov record NCT07521475, source copy `cardio:ctgov-nct07521475-2026-08-03`, retrieved 2026-10-26)
- Completion: 2027-09-23 (anticipated) (ClinicalTrials.gov record NCT07521475, source copy `cardio:ctgov-nct07521475-2026-08-03`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT07521475, source copy `cardio:ctgov-nct07521475-2026-08-03`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07521475-2026-08-03`, retrieved 2026-10-26)

## The registry's words

- Brief title: Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
- Acronym: EVOLVE
- Condition: Type 2 Diabetes Mellitus
- Intervention (Device): Device: Omnipod M System with study CGM
- Intervention (Device): Standard Therapy plus study CGM
- Lead sponsor: Insulet Corporation
- Lead sponsor class: INDUSTRY
- Collaborator: Jaeb Center for Health Research
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Insulet Corporation (`cardio:org-insulet-corporation`)
- Registry lists this organization as a collaborator: Jaeb Center for Health Research (`cardio:org-jaeb-center-for-health-research`)

## Provenance

Content hash: 4f8d3143297fd44c31fb46bb30956c2a4099b8a2968a27a0ecc57c42ad9a2fe1
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
